arrow_back Civic Audit
Share share

Increased Cancer Research Funding and Study on Drug Shortages.

This law significantly boosts funding for the National Cancer Institute (NCI) from 2026 to 2030 to accelerate the search for more effective cancer treatments and cures. It also mandates a detailed study into the causes of critical oncology drug shortages, aiming to improve medication availability for patients. Citizens can expect potentially faster breakthroughs in oncological medicine.
Key points
Substantial additional funding allocated to the National Cancer Institute (NCI) for cancer research over five years (2026-2030), potentially leading to faster medical breakthroughs.
Requirement for a study on the reasons behind cancer drug shortages, including supply chain issues and approval delays, to ensure patients have consistent access to necessary treatments.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_3873
Sponsor: Rep. Fitzpatrick, Brian K. [R-PA-1]
Process start date: 2025-06-10